600557.SS · 康缘药业
China A-shares · RS rating 66 · As of 2026-10-14
| Price | 12.43 CNY |
|---|---|
| 1-day change | +1.6% |
| RS rating (overall / 1M / 3M / 12M) | 66 / 73 / 56 / 43 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 35 / 25 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -0.1% |
| Distance from 52-week high | +24.2% |
| Market cap (USD) | $1.0B |